- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02838303
The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers
July 27, 2023 updated by: Dea Haagensen Kofod, Bispebjerg Hospital
The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
The purpose of this study is to evaluate self-reported symptoms as a proxy for acute organophosphate poisoning by examining self-reported acute organophosphate poisoning symptoms and PchE activity in response to occupational acute organophosphate exposure among farmers in Nepal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- male
- minimum age 18 years
- hand pressured backpack sprayer usage
- used to spray with moderately to extremely hazardous pesticides according to the World Health Organization's (WHO) Pesticide Hazard Classification
Exclusion Criteria:
- usual personal protective equipment use (respirator/mask with particulate filter, face shield, googles, gloves, boots, plastic poncho)
- unwilling to stay pesticide-free seven days prior to each of the two spray sessions
- medical conditions interfering with PchE activity (liver disease, acute infection, chronic malnutrition, heart attack, cancer, obstructive jaundice, inflammation caused by various diseases, or use of pyridostigmine drugs)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group A
Initial spray session: organophosphate.
Crossover spray session: placebo
|
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other Names:
|
|
Other: Group B
Initial spray session: placebo.
Crossover spray session: organophosphate
|
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in self-reported acute organophosphate poisoning symptoms from baseline to follow up
Time Frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
|
Obtained using a structured questionnaire interview.
The definition of symptoms was based on WHO's standardized list of clinical presentations of acute organophosphate poisoning.
|
Obtained just before (baseline) and 30 minutes after (baseline) each spray session
|
|
Change in Plasma Cholinesterase (PchE) activity from baseline to follow up
Time Frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
|
PchE activity was measured with a blood test using a Test-mate Che Cholinesterase System (Model 400) with a PchE Plasma Cholinesterase Assay Kit (Model 470).
|
Obtained just before (baseline) and 30 minutes after (baseline) each spray session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dea H. Kofod, MB, Department of Occupational and Environmental Medicine, Bispebjerg Frederiksberg Hospital, University of Copenhagen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
July 14, 2016
First Submitted That Met QC Criteria
July 17, 2016
First Posted (Estimated)
July 20, 2016
Study Record Updates
Last Update Posted (Actual)
July 28, 2023
Last Update Submitted That Met QC Criteria
July 27, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12205-01-57-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Organophosphate Poisoning
-
Sir Salimullah Medical College Mitford HospitalCompletedOrganophosphorus PoisoningBangladesh
-
Bispebjerg HospitalOdense University Hospital; University of Copenhagen; Dialogos; Nepal Development... and other collaboratorsCompleted
-
Sylhet M.A.G.Osmani Medical CollegeUniversity of EdinburghCompletedOrganophosphate PoisoningBangladesh
-
Ain Shams UniversityRecruiting
-
Amani Hassan Abdel-WahabWithdrawnOrganophosphorus Poisoning
-
Battelle Memorial InstituteTerminatedOrganophosphate Poisoning | Medical CountermeasuresUnited States
-
Postgraduate Institute of Medical Education and...CompletedOrganophosphate PoisoningIndia
-
Sheri Kashmir Institute of Medical SciencesCompleted
-
Sohag UniversityNot yet recruiting
-
University of EdinburghUniversity of PeradeniyaCompletedOrganophosphate PoisoningSri Lanka